Prostate Cancer Clinical Trial

Diffusion Basis Spectrum Imaging of the Prostate

Summary

Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Over 18 years of age and willing and able to provide informed consent.
Patients with no prior diagnosis of prostate cancer, who are planning to undergo prostate biopsy as clinical standard of care ("early detection cohort")

Including those men with:

an elevated PSA and no prior biopsy
an elevated PSA and a negative prior biopsy
Patients with a prior diagnosis of prostate cancer, who are currently managed with active surveillance, who are planning to undergo biopsy as clinical standard of care ("active surveillance cohort")

Exclusion Criteria:

Patients with any clinical contraindication to MRI

*Including but not limited to:

Those with metallic implants, such as pacemakers or implantable cardioverter-defibrillators
Those with cochlear implants
Those with claustrophobia
Those who cannot lie flat for over 1 hour
Patients with prior prostate surgery (e.g. radical prostatectomy, TURP)

Study is for people with:

Prostate Cancer

Estimated Enrollment:

500

Study ID:

NCT04420702

Recruitment Status:

Recruiting

Sponsor:

Washington University School of Medicine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Washington University School of Medicine
Saint Louis Missouri, 63110, United States More Info
Eric H Kim, M.D.
Contact
314-747-9781
[email protected]
Eric H Kim, M.D.
Principal Investigator
Sheng-Kwei Song, Ph.D.
Sub-Investigator
Gerald L Andriole, M.D.
Sub-Investigator
Joseph E Ippolito, M.D., Ph.D.
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

500

Study ID:

NCT04420702

Recruitment Status:

Recruiting

Sponsor:


Washington University School of Medicine

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.